These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

77 related items for PubMed ID: 23899055

  • 1. Cyclodextrin removal of lipemic interference: an attractive alternative to ultracentrifugation for satellite laboratories.
    Roberts CM, Cotten SW.
    Arch Pathol Lab Med; 2013 Aug; 137(8):1027-8. PubMed ID: 23899055
    [No Abstract] [Full Text] [Related]

  • 2. Flocculation of serum lipoproteins with cyclodextrins: application to assay of hyperlipidemic serum.
    Sharma A, Anderson K, Baker JW.
    Clin Chem; 1990 Mar; 36(3):529-32. PubMed ID: 2311226
    [Abstract] [Full Text] [Related]

  • 3. Lipemic interference of ceruloplasmin assays - An evaluation of lipid removal methods.
    Hunsaker JJH, La'ulu SL, Wyness SP, Genzen JR.
    Clin Chim Acta; 2018 May; 480():71-78. PubMed ID: 29391134
    [Abstract] [Full Text] [Related]

  • 4. [Multicenter evaluation on different analyzers of three methods for direct HDL-cholesterol assay].
    Egloff M, Léglise D, Duvillard L, Steinmetz J, Boyer MJ, Ruelland A, Agher R, Beucler I.
    Ann Biol Clin (Paris); 1999 May; 57(5):561-72. PubMed ID: 10518058
    [Abstract] [Full Text] [Related]

  • 5. Polyethylene glycol-6000 as a clearing agent for lipemic serum samples from dogs and the effects on 13 serum assays.
    Thompson MB, Kunze DJ.
    Am J Vet Res; 1984 Oct; 45(10):2154-7. PubMed ID: 6497114
    [Abstract] [Full Text] [Related]

  • 6. Actual situation in the field of standardization of methods for the determination of lipid parameters.
    Jaross W.
    Przegl Lek; 1989 Oct; 46(7):566-73. PubMed ID: 2587782
    [No Abstract] [Full Text] [Related]

  • 7. Problems with measurements caused by high concentrations of serum solids.
    Artiss JD, Zak B.
    Crit Rev Clin Lab Sci; 1987 Oct; 25(1):19-41. PubMed ID: 3301210
    [Abstract] [Full Text] [Related]

  • 8. [Letter: Analyses in lipemic serum opaqueness].
    Rommel K.
    Dtsch Med Wochenschr; 1976 Jul 09; 101(28):1077. PubMed ID: 1278047
    [No Abstract] [Full Text] [Related]

  • 9. [Characteristics of primary changes in serum lipids].
    Diament J, Gastão do Serro-Azul L, Giannini SD.
    Rev Hosp Clin Fac Med Sao Paulo; 1975 Aug 09; 30(4 Suppl):316-25. PubMed ID: 167414
    [No Abstract] [Full Text] [Related]

  • 10. [Study of serum lipids in normal persons and patients with essential hypertension with reference to carbohydrate metabolism].
    Lüthy R.
    Praxis; 1969 Oct 28; 58(43):1365-72 contd. PubMed ID: 5395158
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Lipoprotein and lipoprotein subfraction].
    Itakura H.
    Nihon Rinsho; 2004 Dec 28; 62 Suppl 12():38-41. PubMed ID: 15658257
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Ultracentrifugation does not affect results of analyses for digoxin, cortisol, and calcium in lipemic sera.
    Haythorn P, Sheehan M.
    Clin Chem; 1981 Apr 28; 27(4):634. PubMed ID: 7471437
    [No Abstract] [Full Text] [Related]

  • 16. A simple method for clearing lipemic sera by lipid extraction.
    Hillmann G.
    Z Klin Chem Klin Biochem; 1975 Jul 28; 13(7):327-8. PubMed ID: 171863
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of dewpoint and freezing point osmometry.
    Mercier DE, Feld RD, Witte DL.
    Am J Med Technol; 1978 Nov 28; 44(11):1066-9. PubMed ID: 717430
    [Abstract] [Full Text] [Related]

  • 18. Choosing the appropriate matrix to perform a scientifically meaningful lipemic plasma test in bioanalytical method validation.
    Mayrand-Provencher L, Furtado M, Mess JN, Dumont I, Garofolo F.
    Bioanalysis; 2014 Nov 28; 6(12):1639-46. PubMed ID: 24617519
    [Abstract] [Full Text] [Related]

  • 19. [A method to eliminate lipids from blood plasma in hyperlipidemias to measure activities of proteinases and their inhibitors].
    Belova LA, Ogloblina OG, Tvorogova MG.
    Klin Lab Diagn; 1996 Nov 28; (3):50-1. PubMed ID: 8925221
    [No Abstract] [Full Text] [Related]

  • 20. Evaluation of a pharmacist-managed lipid clinic that uses point-of-care lipid testing.
    Gerrald KR, Dixon DL, Barnette DJ, Williams VG.
    J Clin Lipidol; 2010 Nov 28; 4(2):120-5. PubMed ID: 21122639
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.